We have shown that ML-Ddx4+ cells from advanced non-serous malignancies are able to prime a stemness condition in cancer cells, that may at least partly explain their chemoresistance which leads in the clinical practice to poor prognosis in the late stage of the disease [57,58]. The gene discussed is DDX4; the disease is cancer.